To investigate whether CD38‐EVsMNs could effectively target and reach the tumour cells in mice, four groups (n = 6 per group) were treated with EVsi.v, CD38‐EVsi.v, EVsMNs and CD38‐EVsMNs, respectively. This evidence concerns the gene CD38 and neoplasm.